Taipei, Taiwan

Shu-Jian Liu

This inventor holds 1 USPTO granted patent. Top assignee: Development Center for Biotechnology. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shu-Jian Liu. Retrieved from https://idiyas.com/inventor/shu-jian-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shu-Jian Liu

Introduction

Shu-Jian Liu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical formulations. His work has led to the creation of innovative solutions that enhance drug delivery systems.

Latest Patents

Shu-Jian Liu holds a patent for a controlled release tacrine dosage form. This invention aims to improve the therapeutic efficacy of tacrine, a drug used in the treatment of Alzheimer's disease. The patent showcases his expertise in formulating medications that provide sustained release, thereby optimizing patient outcomes.

Career Highlights

Liu is associated with the Development Center for Biotechnology, where he has been instrumental in advancing research and development initiatives. His role at the center has allowed him to collaborate with other experts in the field, contributing to various innovative projects.

Collaborations

Some of his notable coworkers include Pao-Nien Chen and Chuan-Ming Lai. Together, they have worked on several projects that aim to push the boundaries of biotechnology and improve healthcare solutions.

Conclusion

Shu-Jian Liu's contributions to the field of biotechnology through his patent and collaborative efforts highlight his commitment to innovation. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…